Why the study?
Does valsartan monotherapy or combination with calcium channel blockers reduce albuminuria in an experimental model of diabetic nephropathy?
Population
Accelerated model of diabetic nephropathy in rats
Comparison
Valsartan monotherapy or combination therapy of… vs Diabetic control and comparison between…
Design
Preclinical
Authors
Loading...
Valsartan monotherapy may confer BP-independent renoprotection in diabetic nephropathy models; hypothesis-generating and leaves open clinical translation.
Does valsartan monotherapy or combination with calcium channel blockers reduce albuminuria in an experimental model of diabetic nephropathy?
Valsartan monotherapy provided superior renoprotection compared to equihypotensive combination therapy with calcium channel blockers in a rat model of diabetic nephropathy.
Davis et al. (2003) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: